Northern Trust Corp Dyne Therapeutics, Inc. Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 777,013 shares of DYN stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

777,013

Previous 721,502 7.69%

Holding current value

$10.9 Million

Previous $25.9 Million 29.36%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$23.56 - $35.55 $1.31 Million - $1.97 Million	55,511 Added 7.69%	777,013 $18.3 Million
Q3 2024 Nov 13, 2024	BUY	$31.94 - $47.04 $3.25 Million - $4.79 Million	101,863 Added 16.44%	721,502 $25.9 Million
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $1.72 Million - $2.59 Million	72,604 Added 13.27%	619,639 $21.9 Million
Q1 2024 May 14, 2024	BUY	$13.06 - $29.18 $1.62 Million - $3.62 Million	123,950 Added 29.3%	547,035 $15.5 Million
Q4 2023 Feb 13, 2024	BUY	$6.62 - $13.64 $190,881 - $393,295	28,834 Added 7.31%	423,085 $5.63 Million
Q3 2023 Nov 13, 2023	BUY	$8.6 - $12.18 $114,577 - $162,274	13,323 Added 3.5%	394,251 $3.53 Million
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $908,061 - $1.52 Million	106,455 Added 38.79%	380,928 $4.29 Million
Q1 2023 May 15, 2023	SELL	$10.88 - $15.0 $71,394 - $98,430	-6,562 Reduced 2.33%	274,473 $3.16 Million
Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $135,433 - $199,465	14,454 Added 5.42%	281,035 $3.26 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $3,909 - $8,237	543 Added 0.2%	266,581 $3.39 Million
Q2 2022 Aug 12, 2022	BUY	$4.36 - $10.5 $40,870 - $98,427	9,374 Added 3.65%	266,038 $1.83 Million
Q1 2022 May 13, 2022	SELL	$6.52 - $12.27 $29,802 - $56,086	-4,571 Reduced 1.75%	256,664 $2.47 Million
Q4 2021 Feb 08, 2022	BUY	$11.89 - $16.07 $47,833 - $64,649	4,023 Added 1.56%	261,235 $3.11 Million
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $203,096 - $279,387	-13,019 Reduced 4.82%	257,212 $4.18 Million
Q2 2021 Aug 13, 2021	BUY	$15.94 - $22.33 $1.51 Million - $2.12 Million	94,786 Added 54.03%	270,231 $5.69 Million
Q1 2021 May 12, 2021	BUY	$14.0 - $29.3 $183,890 - $384,855	13,135 Added 8.09%	175,445 $2.72 Million
Q4 2020 Feb 11, 2021	BUY	$16.81 - $23.94 $2.73 Million - $3.89 Million	162,310 New	162,310 $3.41 Million

Others Institutions Holding DYN

# of Institutions

214

Shares Held

103M

Call Options Held

135K

Put Options Held

435K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $725M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Dyne Therapeutics, Inc. Transaction History